Position in PSNL
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$50,213,686
+$27,993,165 QoQ
Shares Held
3,747,290
+7.4% QoQ
Ownership
3.51%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#7
of 157 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PSNL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $1,035,545,424 across 24 Diagnostics & Research names. PSNL ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,339,185 | $255,087,958 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
461,039 | $231,146,511 | |
| 3 | ICLR |
Icon PLC
|
394,362 | $68,504,622 | |
| 4 | WAT |
Waters Corp /De/
|
138,104 | $51,794,522 | |
| 5 | PSNL |
Personalis, Inc.
This page
|
3,747,290 | $50,213,686 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
91,286 | $48,056,601 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
238,810 | $46,142,867 | |
| 8 | A |
Agilent Technologies, Inc.
|
288,030 | $38,259,024 |
All Filings in PSNL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,213,686 | 3,747,290 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $22,220,521 | 3,488,308 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $25,869,164 | 3,249,895 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $15,569,414 | 2,387,947 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $11,542,300 | 1,759,497 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $5,983,791 | 1,704,784 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,721,798 | 297,889 | Shares | Defined | 2025-01-24 | |
| No filing history on record for this holder in this stock. | ||||||